REMINDER: Our user survey closes on Friday, please submit your responses here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
All good things.......Gl :-)
Moneymunch,
I want my money back , all your fault , ramping this up like that :-)
Now this better rise in the next few days or I will be asking you to refund ..
or maybe the Champagne Bar.....;-)
He's up the pub.
More options exercised....need the cash, expecting a rise in sp or an ex employee cashing them in before a restructuring of share options in place, prior to a merger/strategic partnership???
C'mon Evgen, where's the new CEO and who's been accumulating the massive share transfers the last couple of months??? Gla:-)
Arthur,
Agreed ...another game of patience :-)
Exercise of warrants and will still make a packet. No interest here whatsoever and needs news to wake it up.
Franklin had plenty of time before his stock options expired, and so the timing could be significant, very often on merger, aquisition or strategic partnership, stock options in place are generally restructured and can be cancelled completely, especially to ex-employees.
£100k cash in the bank for EVG, and he had a year or two before the options expired, and so the timing could be significant. Gl :-)
Well, would'nt anyone exercise the warrants at that price ?
Looks like the ex CEO has exercised options with Expiry dates 20/11/21 and 22/12/23, hopefully because he's expecting a significant rise in sp as good new arrives. Gla ;-)
https://evgen.com/wp-content/uploads/2015/10/Evgen-Annual-Report-2020.pdf
RNS Number : 0460S
Evgen Pharma PLC
06 July 2020
Evgen Pharma plc
("Evgen" or "the Company")
Share option exercise and issue of equity
Evgen (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that it has received notice to exercise options over 2,957,600 ordinary shares in the Company. The options have been exercised pursuant to grants under the Company's share option plans.
Accordingly, the Company has issued and allotted 2,957,600 new ordinary shares of 0.25 pence each ("New Ordinary Shares"). The New Ordinary Shares rank pari passu with the Company's existing issued ordinary shares. Application has been made to admit the New Ordinary Shares to trading on AIM and dealings in these shares are expected to commence at 8.00 a.m. on 9 July 2020.
There are no shares held in treasury, therefore following the admission of the New Ordinary Shares the total number of voting rights in the Company will be 135,613,863. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest under the Disclosure and Transparency Rules.